A Retrospective Observational Study of Risk Factors for Denosumab-Related Osteonecrosis of the Jaw in Patients with Bone Metastases from Solid Cancers

This single-center retrospective observational study aimed to identify risk factors for developing denosumab-related osteonecrosis of the jaw (DRONJ) in stage IV solid cancer patients with bone metastases. In total, 123 consecutive patients who had received 120 mg of denosumab every 4 weeks at least...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuma, Satoe, Matsuda, Yuhei, Nariai, Yoshiki, Karino, Masaaki, Suzuki, Ritsuro, Kanno, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281320/
https://www.ncbi.nlm.nih.gov/pubmed/32408510
http://dx.doi.org/10.3390/cancers12051209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281320/
https://www.ncbi.nlm.nih.gov/pubmed/32408510
http://dx.doi.org/10.3390/cancers12051209

Ejemplares similares